98%
921
2 minutes
20
There is growing experimental evidence that many respiratory viruses-including influenza and SARS-CoV-2-can interact, such that their epidemiological dynamics may not be independent. To assess these interactions, standard statistical tests of independence suggest that the prevalence ratio-defined as the ratio of co-infection prevalence to the product of single-infection prevalences-should equal unity for non-interacting pathogens. As a result, earlier epidemiological studies aimed to estimate the prevalence ratio from co-detection prevalence data, under the assumption that deviations from unity implied interaction. To examine the validity of this assumption, we designed a simulation study that built on a broadly applicable epidemiological model of co-circulation of two emerging or seasonal respiratory viruses. By focusing on the pair influenza-SARS-CoV-2, we first demonstrate that the prevalence ratio systematically underestimates the strength of interaction, and can even misclassify antagonistic or synergistic interactions that persist after clearance of infection. In a global sensitivity analysis, we further identify properties of viral infection-such as a high reproduction number or a short infectious period-that blur the interaction inferred from the prevalence ratio. Altogether, our results suggest that ecological or epidemiological studies based on co-detection prevalence data provide a poor guide to assess interactions among respiratory viruses.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753173 | PMC |
http://dx.doi.org/10.1098/rspb.2021.2358 | DOI Listing |
BMC Infect Dis
August 2025
Christiana Care Health System, Newark, DE, USA.
Background: Evaluating the burden of respiratory syncytial virus (RSV) and influenza among young children in LMICs is crucial to inform implementation policies, given the importance of maternal influenza and RSV vaccination, which may not yet be widely available.
Methods: This study established a one-year surveillance of severe acute respiratory infection (SARI) from June 2022-2023 in hospitalized children 1-24 months from rural West Bengal India. We tested nasopharyngeal swabs collected from children admitted with SARI using multiplex real-time PCR for influenza, RSV, SARS-CoV-2, with a subset (N = 81) tested for additional respiratory pathogens and analyzed clinical features, factors influencing infections, and hospitalization duration.
Clin Infect Dis
August 2025
Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Front Public Health
July 2025
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Background: Following China's post-COVID-19 reopening strategy, intermittent small-scale outbreaks of respiratory pathogen infections have been observed in the Beijing region. This single-center study aims to characterize the epidemiological features and co-detection patterns of respiratory pathogens in Beijing, providing a scientific basis for the prevention and control of respiratory infectious diseases.
Methods: We performed a retrospective analysis of 19,535 patients undergoing SARS-CoV-2 testing and 12,372 patients screened for six respiratory pathogens, including (MP), respiratory syncytial virus (RSV), human rhinovirus (HRV), influenza A virus (IAV), adenovirus (ADV), and influenza B virus (IBV) at Peking University People's Hospital from January 2023 to December 2024.
BMC Infect Dis
July 2025
Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.
Introduction: The COVID-19 pandemic has significantly affected healthcare systems worldwide, impacting the occurrence and management of respiratory illnesses. This has also influenced respiratory infections' role in childhood mortality. Surveillance of common respiratory viruses in Ghana is limited, making it crucial to assess the prevalence of respiratory viral infections, particularly in children, in the post-pandemic era.
View Article and Find Full Text PDFVaccines (Basel)
June 2025
National Centre of Infectious and Parasitic Diseases, 26 Yanko Sakazov Blvd., 1504 Sofia, Bulgaria.
Introduction: An effective vaccination strategy requires monitoring serotype changes by geography and age. This study analyzed serotypes in healthy children under 6 years of age vaccinated with PCV10 in Bulgaria from October 2021 to May 2025.
Methods: A total of 569 children were screened for the and genes viareal-time polymerase chain reaction (real-time PCR).